COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
© 2021. Crown..
The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Rheumatology international - 42(2022), 1 vom: 26. Jan., Seite 23-29 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sen, Parikshit [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoimmune diseases |
|---|
| Anmerkungen: |
Date Completed 25.01.2022 Date Revised 22.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00296-021-05046-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333176251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333176251 | ||
| 003 | DE-627 | ||
| 005 | 20231225221117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00296-021-05046-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333176251 | ||
| 035 | |a (NLM)34779868 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sen, Parikshit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 vaccination in autoimmune disease (COVAD) survey protocol |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.01.2022 | ||
| 500 | |a Date Revised 22.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Crown. | ||
| 520 | |a The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Autoimmune diseases | |
| 650 | 4 | |a COVAD | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Survey | |
| 650 | 4 | |a Vaccination | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Gupta, Latika |e verfasserin |4 aut | |
| 700 | 1 | |a Lilleker, James B |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Vishwesh |e verfasserin |4 aut | |
| 700 | 1 | |a Kardes, Sinan |e verfasserin |4 aut | |
| 700 | 1 | |a Milchert, Marcin |e verfasserin |4 aut | |
| 700 | 1 | |a Gheita, Tamer |e verfasserin |4 aut | |
| 700 | 1 | |a Salim, Babur |e verfasserin |4 aut | |
| 700 | 1 | |a Velikova, Tsvetelina |e verfasserin |4 aut | |
| 700 | 1 | |a Gracia-Ramos, Abraham Edgar |e verfasserin |4 aut | |
| 700 | 1 | |a Parodis, Ioannis |e verfasserin |4 aut | |
| 700 | 1 | |a O'Callaghan, Albert Selva |e verfasserin |4 aut | |
| 700 | 1 | |a Nikiphorou, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Ai Lyn |e verfasserin |4 aut | |
| 700 | 1 | |a Cavagna, Lorenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Saavedra, Miguel A |e verfasserin |4 aut | |
| 700 | 1 | |a Shinjo, Samuel Katsuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Ziade, Nelly |e verfasserin |4 aut | |
| 700 | 1 | |a Knitza, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Kuwana, Masataka |e verfasserin |4 aut | |
| 700 | 1 | |a Cagnotto, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Nune, Arvind |e verfasserin |4 aut | |
| 700 | 1 | |a Distler, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Chinoy, Hector |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Vikas |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Rohit |e verfasserin |4 aut | |
| 700 | 0 | |a COVAD Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Barman, Bhupen |e investigator |4 oth | |
| 700 | 1 | |a Singh, Yogesh Preet |e investigator |4 oth | |
| 700 | 1 | |a Ranjan, Rajiv |e investigator |4 oth | |
| 700 | 1 | |a Jain, Avinash |e investigator |4 oth | |
| 700 | 1 | |a Pandya, Sapan C |e investigator |4 oth | |
| 700 | 1 | |a Malaviya, A N |e investigator |4 oth | |
| 700 | 1 | |a Pilania, Rakesh Kumar |e investigator |4 oth | |
| 700 | 1 | |a Sharma, Aman |e investigator |4 oth | |
| 700 | 1 | |a Manoj, M Manesh |e investigator |4 oth | |
| 700 | 1 | |a Gupta, Vikas |e investigator |4 oth | |
| 700 | 1 | |a Kavadichanda, Chengappa G |e investigator |4 oth | |
| 700 | 1 | |a Patro, Pradeepta Sekhar |e investigator |4 oth | |
| 700 | 1 | |a Ajmani, Sajal |e investigator |4 oth | |
| 700 | 1 | |a Phatak, Sanat |e investigator |4 oth | |
| 700 | 1 | |a Goswami, Rudra Prosad |e investigator |4 oth | |
| 700 | 1 | |a Chowdhury, Abhra Chandra |e investigator |4 oth | |
| 700 | 1 | |a Mathew, Ashish Jacob |e investigator |4 oth | |
| 700 | 1 | |a Shenoy, Padnamabha |e investigator |4 oth | |
| 700 | 1 | |a Asranna, Ajay |e investigator |4 oth | |
| 700 | 1 | |a Bommakanti, Keerthi Talari |e investigator |4 oth | |
| 700 | 1 | |a Shukla, Anuj |e investigator |4 oth | |
| 700 | 1 | |a Naveen, R |e investigator |4 oth | |
| 700 | 1 | |a Cansu, Döndü Üsküdar |e investigator |4 oth | |
| 700 | 1 | |a Pauling, John D |e investigator |4 oth | |
| 700 | 1 | |a Wincup, Chris |e investigator |4 oth | |
| 700 | 1 | |a Chatterjee, Tulika |e investigator |4 oth | |
| 700 | 1 | |a Kim, Minchul |e investigator |4 oth | |
| 700 | 1 | |a Giannini, Margherita |e investigator |4 oth | |
| 700 | 1 | |a Del Papa, Nicoletta |e investigator |4 oth | |
| 700 | 1 | |a Sambataro, Gianluca |e investigator |4 oth | |
| 700 | 1 | |a Fabiola, Atzeni |e investigator |4 oth | |
| 700 | 1 | |a Govoni, Marcello |e investigator |4 oth | |
| 700 | 1 | |a Parisi, Simone |e investigator |4 oth | |
| 700 | 1 | |a Bocci, Elena Bartoloni |e investigator |4 oth | |
| 700 | 1 | |a Sebastiani, Gian Domenico |e investigator |4 oth | |
| 700 | 1 | |a Fusaro, Enrico |e investigator |4 oth | |
| 700 | 1 | |a Sebastiani, Marco |e investigator |4 oth | |
| 700 | 1 | |a Quartuccio, Luca |e investigator |4 oth | |
| 700 | 1 | |a Franceschini, Franco |e investigator |4 oth | |
| 700 | 1 | |a Sainaghi, Pier Paolo |e investigator |4 oth | |
| 700 | 1 | |a Orsolini, Giovanni |e investigator |4 oth | |
| 700 | 1 | |a De Angelis, Rossella |e investigator |4 oth | |
| 700 | 1 | |a Danielli, Maria Giovanna |e investigator |4 oth | |
| 700 | 1 | |a Traboco, Lisa S |e investigator |4 oth | |
| 700 | 1 | |a Wibowo, Suryo Anggoro Kusumo |e investigator |4 oth | |
| 700 | 1 | |a Serrano, Jorge Rojas |e investigator |4 oth | |
| 700 | 1 | |a La Torre, Ignacio García-De |e investigator |4 oth | |
| 700 | 1 | |a Tehozol, Erick Adrian Zamora |e investigator |4 oth | |
| 700 | 1 | |a Loarce-Martos, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Prieto-González, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Gil-Vila, Albert |e investigator |4 oth | |
| 700 | 1 | |a Aranega, Raquel |e investigator |4 oth | |
| 700 | 1 | |a Nakashima, Ran |e investigator |4 oth | |
| 700 | 1 | |a Sato, Shinji |e investigator |4 oth | |
| 700 | 1 | |a Kimura, Naoki |e investigator |4 oth | |
| 700 | 1 | |a Kaneko, Yuko |e investigator |4 oth | |
| 700 | 1 | |a Tomaras, Stylianos |e investigator |4 oth | |
| 700 | 1 | |a Gromova, Margarita Aleksandrovna |e investigator |4 oth | |
| 700 | 1 | |a Aharonov, Or |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d 1985 |g 42(2022), 1 vom: 26. Jan., Seite 23-29 |w (DE-627)NLM012644315 |x 1437-160X |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:1 |g day:26 |g month:01 |g pages:23-29 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00296-021-05046-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 1 |b 26 |c 01 |h 23-29 | ||